i also loved your analysis of what is happening, and i want

New Post Public Reply Private Reply Replies (0) Message Board
Msowid Buildit #9899
271
i also loved your analysis of what is happening, and i want to add my 2 cents to your great vision of what is to come, and your system of grading is very new to me on a bulletin board, maybe it should be utilized by all.....

I've been mostly reading but not posting lately for 2 reasons.... 1) I've been busy at work (and I can't be "real time" on reading/posting) and 2) I feel as though we are so in the dark on so many topics that it is not a good time to buy OR sell, and many of my thoughts would be pure (and worthless) speculation.

Here are some of my thoughts, in no particular order as they spew from my somewhat overwhelmed head. The number after each item is my perceived level of our current level of good information on the topic (0-5, 0 = lowest, 5 = highest). Please feel free to enlighten me with info that you feel proves me wrong.

1) There is no clarity on the CMF issue. We don't really know if they have been or will be penalized. We don't know if other restricted shareholders are selling or if CMF continues to sell. (1)
...you are completely right, Joe himself stated that he does not know what to do, and is leaving this to the lawyers to work it out.....so a grade of 1 or maybe even .5 is really true.
2) The new NGIO dividend sounds positive, and I'm happy to see SOMETHING... but we don't really have the info to judge that. We get 2:5 NGIO shares. I THINK that's great, as it adds to the shares I have received in a rather large way. However, we don't know how many total shares of NGIO there will be, and we have no way to value the company even if we did. (0)
...this one i have to disagree with you, an oncology company coming on the scene and is touting some good relation with Merck Keytruda is not a shabby thing....so you getting some shares of this entity, even though, not alive yet....but once so....is GREEEEAAAAT..so maybe a change of 0 to a 4....on this one...
3) The new GNBT div... it's good to see there is a plan. But we don't know who receives the dividend. I assume from the wording (or lack thereof), unless they state otherwise, that ALL shareholders will receive it. Therefore, it will simply be dilutive. (3)
....you are completely right in this assumption....generex was and is not being reactive fast enough to tell us the info necessary to make some good decisions about our investment....
4) NGIO spin - we don't have a date, and we don't know how much money it will raise ($100s of millions???). It seems to me that, with all of the pieces that are still in process, this could be at least a couple of months. (1).
....so what is wrong with a couple of months?...or maybe even longer....have you seen some of these companies when they go live, and they are in oncology research, how their stock behaves,,,,
5) NGIO uplist to Naz - no way to gauge this, other than for Joe to say it's going great. That doesn't resonate with me any more, frankly. (1)
....same as number 4....

6) GNBT uplist to Naz - I don't see this in our near future, given recent execution history and open items. One thing seems clear to me... Joe doesn't think this is happening soon. Joe states that the S-1 for GNBT has "always been part of the plan". That may be a true statement, but it is playing games with words (IMO). It has always been part of the plan, but it was part of the plan for AFTER uplisting. Joe stated numerous times that it was stupid to raise the money on the OTC... and yet here we are with $40MM (or more) being raised while we sit on the OTC. I'm not counting my Naz chickens until they hatch. (2)

7) S-1 $ for GNBT - when will we have it? In the coming days? Weeks? Months? What are the terms? How much will it dilute our holdings? (2)
....having a bank to invest 40 mil in a company that is trying to ''put pieces together'' is not as easy as one thinks.....so i ask that you change this to a 4 if you would....
8) Revenues - What divisions are currently producing revenues? How much? How long will it take for various divisions to ramp up once the S-1 $ is in the bank? Other than "$250MM in the first 12 months, low-ball #", what are the projections for sales in the various divisions? Some think this is an unimportant piece of our short-term pie. As we flounder on the OTC, I believe this is a HUGE opportunity for buying pressure... as the company is currently priced for failure. Any hint of actual business success (not further enticements to hold or future acquisition targets) will be what finally gets this stock moving (IMO). (1... moving to a 2 when we see the Q on 12/16 (barring an extension... oh, please, can we report without an extension?!).... hopefully moving to a 3.5-4 by the following Q ~3/15)
This one i am going to tackle from a stock investor', more than a gnbt investor' point of view....and yes THERE IS A DIFFERENCE....revenue is great...for a 2 mil and a 5 mil type company....but here you have what is called potential revenue...not true revenue....potential revenue for an oncology company is so exponential in comparison,,,,an M. can be changed to a B. in a few strokes....and yes an M. is a million and a B. is a billion...


All that said, I still hold, as I believe many of you are. Of course, who would sell here, as many have stated.

On the flip side, with so much uncertainty, who would buy?

I am still bullish long-term,and look forward to the GNBT S-1 $ becoming available, the NGIO spin/uplist/trading (and $), revenue info being made available (and revenue occurring from more places), putting the dividends behind us, etc.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 5

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

International Isotopes Enhances Growth with New Facilities

Updated Category News Views 139

International Isotopes Expands Its Operational Footprint International Isotopes, Inc. (OTCQB: INIS) has announced a significant expansion of its operational capabilities with a strategic land acquisition and a new facility lease agreement. This initiative is part of a broader strategy aimed at enhancing the Company's footprint in the radiopharmaceuticals sector. Strategic...

Continue Reading
Humana Achieves Top Honors in Customer Experience Again

Updated Category News Views 80

Humana Excels in Customer Experience for Four Straight Years Humana has once again secured the top position in customer experience among health insurers, according to a recent survey conducted by Forrester. This marks the fourth consecutive year that Humana has achieved this prestigious recognition, reaffirming its commitment to delivering exceptional service and care to...

Continue Reading
BrainStorm Cell Therapeutics Presents Insights into ALS Treatment

Updated Category News Views 128

BrainStorm Cell Therapeutics Webinar on ALS Treatments BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a prominent innovator in adult stem cell therapeutics for neurodegenerative diseases, will be hosting an insightful webinar on current developments in treating amyotrophic lateral sclerosis (ALS). This event is designed to provide essential updates and perspectives...

Continue Reading
Celebrating Excellence: The 2024 Employer Branding Awards Unveiled

Updated Category News Views 235

Overview of the Employer Branding Creativity Awards The "2024 Employer Branding Creativity Awards" organized by the Employer Branding Institute, recognized 75 exemplary companies for their innovative contributions to employer branding. Sponsored by Jaguar Land Rover China, this prestigious event not only celebrates creativity but also demonstrates the rising influence of...

Continue Reading
Battery Recycling Market Expected to Hit $77.1 Billion by 2034

Updated Category News Views 210

Battery Recycling Market Overview The battery recycling market is gaining remarkable traction worldwide, projected to soar to $77.1 billion by 2034. This forecast represents a significant growth trajectory from a valuation of $26.9 billion in 2024, indicating a compound annual growth rate (CAGR) of 11.2% from 2025 to 2034. Impact of Government Regulations Government...

Continue Reading